Trial intelligence / Profile preview

Defibrotide with MPT in Advanced/Refractory Multiple Myeloma

NCT00406978Phase 2Completed

Start
Feb 2006
Primary completion
Sep 2010
Modality
Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of defibrotide in multiple myeloma (MM). Started Feb 2006; status: completed.

02

Drugs

defibrotide
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT00406978.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00406978.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call